KB-R7785 is a novel matrix metalloproteinase (MMP) inhibitor, which improves insulin sensitivity by inhibiting TNF-alpha production. KB-R7785 can be used for diabetes research. KB-R7785 has a protective efficacy against focal cerebral ischemia[1][2].
Molecular Weight:
349.42
CAS Number:
[168158-16-5]
Formula:
C18H27N3O4
Target:
MMP
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted